Coronary Intervention Drug Eluting Stent Market

Coronary Intervention Drug Eluting Stent Market contains market size and forecasts of Coronary Intervention Drug Eluting Stent in global, including the following market information:

Global Coronary Intervention Drug Eluting Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Coronary Intervention Drug Eluting Stent Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Coronary Intervention Drug Eluting Stent companies in 2021 (%)

The global Coronary Intervention Drug Eluting Stent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Below 40 ?m Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Coronary Intervention Drug Eluting Stent include Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions and Comed BV, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Coronary Intervention Drug Eluting Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Coronary Intervention Drug Eluting Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, by Type, 2021 (%)

Below 40 ?m

40 ?m- 65 ?m

Above 65 ?m

Global Coronary Intervention Drug Eluting Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Others

Global Coronary Intervention Drug Eluting Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Coronary Intervention Drug Eluting Stent Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Coronary Intervention Drug Eluting Stent revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Coronary Intervention Drug Eluting Stent revenues share in global market, 2021 (%)

Key companies Coronary Intervention Drug Eluting Stent sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Coronary Intervention Drug Eluting Stent sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Synlas GmbH

YILSON

BrosMed Medical

SCITECH Medical

Wellinq

Degania Silicone

Alvimedica

Interventional Medical Device Solutions

Comed BV

iVascular

LEPU Medical

Eurocor Tech GmbH

OrbusNeich

Endocor GmbH

Meril Life Sciences

Acrostak

Boston Scientific Corporation

B. Braun

Biotronik

Abbott

MicroPort Medical Group

Philips

Terumo Corporation